This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

2022 Information Coming Soon!

Harald Wajant, Ph.D.
Professor, Department of Internal Medicine II at University Hospital Würzburg


Harald Wajant is Professor at the Department of Internal Medicine II of the University Hospital Würzburg and head the Division of Molecular Internal Medicine. He graduated in the Institute of Botany of the University of Stuttgart, Germany in 1993 and was then a postdoctoral research fellow and group leader at the Institute of Cell Biology and Immunology. Since 2003 he is Professor at the University Hospital Würzburg.

In the 1990s during his time in Stuttgart, Professor Wajant worked on the cloning, expression and biotechnological application of plant hydroxynitrile lyases but also started to work in the completely different field of TNF receptor signaling. Since then the scientific interests of Professor Wajant fully shifted to the TNF field and are now focused on the mechanisms of TNF receptor activation, apoptotic and non-apoptotic death receptor signaling and the development of antibodies and TNF ligand fusion proteins targeting TNF receptors.

Agenda Sessions

  • Exploiting and Understanding Avidity Engineering of Antibodies

  • Valency and Cell Surface-anchoring Are Key Factors Determining Agonism of Category II TNFR Antibodies

    On Demand